NCT03762122 2022-11-09Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)Swiss Cancer InstitutePhase 2 Terminated15 enrolled
NCT01367275 2020-09-03Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGFM.D. Anderson Cancer CenterPhase 2 Terminated8 enrolled 5 charts
NCT02747797 2018-08-02Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway AberrationsUniversity of California, San DiegoPhase 2 Withdrawn
NCT02846766 2018-08-02Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR SignalingUniversity of California, San DiegoPhase 2 Withdrawn